Plain-English translation of NCT06263829 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hepatitis C research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial examined whether a smartphone app called Tappt could help people with hepatitis C virus take their oral medication more reliably. Participants used the app to track when they took glecaprevir/pibrentasvir or sofosbuvir/velpatasvir, and researchers compared how well people using the medication did with the app versus people who took the same treatment without it.
Taking hepatitis C medication exactly as prescribed is critical for achieving a cure, but many people struggle to remember doses or stick with treatment. This trial tested whether a digital tool could help pharmacists support patients and improve their chances of successfully completing treatment.
Participants downloaded the Tappt app on their smartphone and used it to record each time they took their hepatitis C medication. The app used passive tags that participants scanned to track adherence throughout their treatment period. Researchers then compared how well participants who used the app followed their medication schedule and achieved treatment success compared to similar patients from medical records who had received the same medication without the app.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States